Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AbbVie Inc. | 178,737 | reported | 27 Feb 2026 | tx 68+1,050,199−362,504 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Feb 2026 | TAX_WITHHOLDING | AbbVie Inc. | 36,523 | 232.08 USD | |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 14,452 | 0.00 USD | |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 12,030 | 0.00 USD | |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 33,833 | 0.00 USD | |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 22,124 | 0.00 USD | |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 81,251 | 0.00 USD | deriv |
| 28 Feb 2025 | TAX_WITHHOLDING | AbbVie Inc. | 27,186 | 205.02 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 14,454 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 10,146 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 24,732 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 12,030 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 83,333 | 0.00 USD | deriv |
| 28 Feb 2024 | TAX_WITHHOLDING | AbbVie Inc. | 37,638 | 178.99 USD | |
| 29 Feb 2024 | EXERCISE | AbbVie Inc. | 11,420 | 61.36 USD | |
| 29 Feb 2024 | EXERCISE | AbbVie Inc. | 10,140 | 54.86 USD | |
| 29 Feb 2024 | SALE | AbbVie Inc. | 21,560 | 176.44 USD | |
| 29 Feb 2024 | SALE | AbbVie Inc. | 47,319 | 176.46 USD | |
| 29 Feb 2024 | EXERCISE | AbbVie Inc. | 10,140 | 54.86 USD | deriv |
| 29 Feb 2024 | EXERCISE | AbbVie Inc. | 11,420 | 61.36 USD | deriv |
| 15 Feb 2024 | GRANT_AWARD | AbbVie Inc. | 49,565 | 0.00 USD | |
| 15 Feb 2024 | GRANT_AWARD | AbbVie Inc. | 13,216 | 0.00 USD | |
| 15 Feb 2024 | GRANT_AWARD | AbbVie Inc. | 10,146 | 0.00 USD | |
| 15 Feb 2024 | GRANT_AWARD | AbbVie Inc. | 12,030 | 0.00 USD | |
| 15 Feb 2024 | GRANT_AWARD | AbbVie Inc. | 59,888 | 0.00 USD | deriv |
| 28 Feb 2023 | TAX_WITHHOLDING | AbbVie Inc. | 48,335 | 154.28 USD |